1. Chung CY, Seo H, Sonntag KC, Brooks A, Lin L, Iasacson O. Cell type specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum. Mol. Genet. 2005; 14: 1709-1725
2. Mendez I, Sanchez-Pernaute R, Cooper O, Vinuela A, Ferrari D, Bjoerklund L, Dagher A, and Isacson O. Cell type analysis of fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005 128(7):1498-1510
3. Cooper O and Isacson O. Intrastiatal Transforming Growth Factor Delivery to a Model of Parkinson's Disease Induces Proliferation and Migration of Endogenous Adult Neural Progenitor Cells without Differentiation into Dopaminergic Neurons. J. Neurosci., Oct 13, 2004, 24(41):8924-8931
4. Sanchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell AL and Isacson O. Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat mod of Parkinson's disease.
5. Isacson O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurology 2003 Jul; 2(7):417-24.